Compare KOF & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOF | COO |
|---|---|---|
| Founded | 1979 | 1980 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Ophthalmic Goods |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6B | 16.1B |
| IPO Year | 1993 | N/A |
| Metric | KOF | COO |
|---|---|---|
| Price | $94.93 | $83.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $104.00 | $88.55 |
| AVG Volume (30 Days) | 151.7K | ★ 2.4M |
| Earning Date | 02-20-2026 | 12-04-2025 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ 8.54 | N/A |
| EPS | ★ 6.13 | 1.87 |
| Revenue | ★ $15,805,291,584.00 | $4,092,400,000.00 |
| Revenue This Year | $7.38 | $6.56 |
| Revenue Next Year | $6.40 | $5.32 |
| P/E Ratio | ★ $15.44 | $44.87 |
| Revenue Growth | ★ 8.34 | 5.06 |
| 52 Week Low | $72.68 | $61.78 |
| 52 Week High | $101.74 | $100.24 |
| Indicator | KOF | COO |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 62.06 |
| Support Level | $93.66 | $80.23 |
| Resistance Level | $96.87 | $85.04 |
| Average True Range (ATR) | 1.92 | 1.38 |
| MACD | -0.27 | -0.20 |
| Stochastic Oscillator | 58.12 | 67.88 |
Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of Coca-Cola in volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through modern trade, traditional trade, and the on-premises channel. Mexico and Brazil make up 80% of the total volume and sales, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Femsa and Coca-Cola hold 47% and 28% economic interests in Coca-Cola Femsa through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the voting power.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.